Acute Tracheobronchitis Clinical Trial
Official title:
a Study of Clinical Safety Monitoring and the Mechanism of Anaphylactic Reaction Used Reduning(a Chinese Medicine Injection)in Hospitals in China
This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy
of Chinese Medical Sciences in January 2013.
The purpose of this study is to make a event monitoring to see whether Reduning injection is
safe and the characteristic and mechanism of anaphylactic reaction used Reduning injection in
hospitals in China.
It is very common that Chinese Medicine Injection used in hospitals in mainland China.
However safety problems rose in recent years. There could be many uncertain factors influence
Chinese Medicine Injection in clinical practice.
In order to ensure the safety of public drug use and lower drug-induced risks, a registry
study for Reduning injection safety surveillance with 3000 patients will be conducted from
Jan.2013 to Mar.2013.At the same time,Patients who have anaphylactic reaction are selected as
the allergic group and not have anaphylactic reaction are selected as the control group.The
proportion of allergic group and control group is 1:4.All the patients who are selected
should draw blood.
Eligibility criteria Patients who will use Reduning injection in selected hospitals.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT03461692 -
A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection（a Chinese Medicine Injection）Used in Hospitals in China
|
N/A |